Remox250 mg

Remox 250 mg is indicated in open angle glaucoma, secondary glaucoma and as an adjuvant in the treatment of edema and epilepsy.

Carbonic anhydrase inhibitor

Remox 250 mg is a carbonic anhydrase inhibitor. This enzyme catalyzes the reversible reaction involving the hydration of carbon-di-oxide and the dehydration of carbonic acid. In the eye, this inhibitory action of Remox 250 mg decreases the secretion of aqueous humor and results in a drop in intraocular pressure, a reaction considered desirable in case of glaucoma. Inhibition of carbonic anhydrase in the central nervous system appears to retard abnormal paroxysmal and excessive discharge from central nervous system neurons. So, Remox 250 mg is also used as an adjuvant in the treatment of epilepsy.

Adults : Initially 250 mg (1 tablet) 4 times daily. Dose should be adjusted later with individual need. Children : ½ to 2 tablets in divided doses. In intraocular pressure: 1 tablet 6 hourly. In acute condition, dose should be started with 2 tablets followed by 1 tablet 6 hourly or as directed by the physician

Adults : Initially 250 mg (1 tablet) 4 times daily. Dose should be adjusted later with individual need. Children : ½ to 2 tablets in divided doses. In intraocular pressure: 1 tablet 6 hourly. In acute condition, dose should be started with 2 tablets followed by 1 tablet 6 hourly or as directed by the physician

Remox 250 mg is contraindicated in cases of marked kidney and liver diseases or dysfunction, in situations in which sodium and or potassium blood serum levels decreased. Remox 250 mg is also contraindicated in patients with chronic noncongestive angle closure glaucoma

Common side effects are headache, drowsiness, dizziness, fatigue, anorexia, polyurea, insomnia, gastrointestinal upset.

There are no adequate and well controlled studies in pregnant women and neonates. So, Remox 250 mg should be used with care in those physiological conditions.

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Carbonic anhydrase inhibitor

Remox 250 mg is a carbonic anhydrase inhibitor. This enzyme catalyzes the reversible reaction involving the hydration of carbon-di-oxide and the dehydration of carbonic acid. In the eye, this inhibitory action of Remox 250 mg decreases the secretion of aqueous humor and results in a drop in intraocular pressure, a reaction considered desirable in case of glaucoma. Inhibition of carbonic anhydrase in the central nervous system appears to retard abnormal paroxysmal and excessive discharge from central nervous system neurons. So, Remox 250 mg is also used as an adjuvant in the treatment of epilepsy.

There are no adequate and well controlled studies in pregnant women and neonates. So, Remox 250 mg should be used with care in those physiological conditions.